Efficacy and pharmacokinetics of a switch from a regimen consisting of emtricitabine, nevirapine and tenofovir to rilpivirine, emtricitabine and tenofovir in virologically suppressed HIV-1 infected patients.
Read time: 1 mins
Last updated:30th Aug 2012
To evaluate the safety of a switch from nevirapine to rilpivarine.
|Study start date||2012-08-30|